Efficacy and Safety of Hydroxyurea in the Treatment of Sickle Cell Anemia Children in Jos, North Central Nigeria

被引：1
|
作者：
Ofakunrin, Akinyemi Olugbenga David [1 ]
Adekola, Kehinde U. [2 ]
Oguche, Stephen [3 ]
Okpe, Edache Sylvanus [3 ]
Sagay, Atiene Solomon [4 ]
机构：
[1] Univ Jos, Dept Paediat, Jos, Nigeria
[2] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[3] Univ Jos, Jos Univ Teaching Hosp, Dept Paediat, Jos, Nigeria
[4] Univ Jos, Jos Univ Teaching Hosp, Dept Obstet & Gynaecol, Jos, Nigeria
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-115598
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1081
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Impact of hydroxyurea on lymphocyte subsets in children with sickle cell anemia
    Khalid I. Elsayh
    Khaled Saad
    Helal F. Hetta
    Mervat A. M. Youssef
    Mostafa M. Embaby
    Ismail L. Mohamed
    Safwat M. Abdel-Aziz
    Zeinab Albadry M. Zahran
    Amira Elhoufey
    Aliaa M. A. Ghandour
    Asmaa M. Zahran
    Pediatric Research, 2023, 93 : 918 - 923
  • [42] Early hydroxyurea use is neuroprotective in children with sickle cell anemia
    Karkoska, Kristine
    Pfeiffer, Amanda
    Beebe, Dean W.
    Quinn, Charles T.
    Niss, Omar
    McGann, Patrick T.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (10) : E368 - E370
  • [43] Safety and efficacy of dose-escalation hydroxyurea therapy in very young children with sickle cell anemia: A retrospective cohort study
    George, Alex
    Tran, Jennifer N.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (09)
  • [44] The safety and efficacy of hydroxyurea in 2 to 5 year old children with sickle cell disease
    Hoppe, C
    Van Warmerdam, J
    Allen, K
    Quirolo, K
    Vichinsky, E
    Styles, L
    PEDIATRIC RESEARCH, 1999, 45 (04) : 147A - 147A
  • [45] The effects of hydroxyurea treatment in Bahraini patients with sickle cell anemia and sickle cell thalassemias
    Shome, D. K.
    Al Ajmi, A.
    Radhi, A.
    Jassim, E.
    Salih, F. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 534 - 534
  • [46] The Safety and Efficacy of Hydroxyurea in 2 to 5 Year Old Children with Sickle Cell Disease
    Carolyn Hoppe
    Jane Van Warmerdam
    Katie Allen
    Keith Quirolo
    Elliott Vichinsky
    Lori Styles
    Pediatric Research, 1999, 45 (7) : 147 - 147
  • [47] Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in children
    Strouse, John J.
    Heeney, Matthew M.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (02) : 365 - 371
  • [48] THE INCIDENCE OF SICKLE-CELL-ANEMIA AMONG DIABETIC-PATIENTS IN JOS, NIGERIA
    ADOGA, GI
    OHAERI, CO
    ALIYU, SI
    MEDICAL SCIENCE RESEARCH, 1995, 23 (07): : 475 - 476
  • [49] Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
    Kabuyi, Paul Lumbala
    Mbayabo, Gloire
    Ngole, Mamy
    Zola, Aime Lumaka
    Race, Valerie
    Matthijs, Gert
    Van Geet, Chris
    Tshilobo, Prosper Lukusa
    Devriendt, Koenraad
    Mikobi, Tite Minga
    EJHAEM, 2023, 4 (03): : 595 - 601
  • [50] Hydroxyurea marketed for sickle cell anemia
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (09) : 875 - 875
12345